If avxl has what dr Missling says we have and we beat Biogen handily on all endpoints we go totally frontal in our approach starting this coming Thursday. I suspect that we have a press release Thursday morning followed by some CLEAR unambiguous explosive statements/slides regarding Blarcamisine vs Biogen. What I hope and pray is that we ( the company), has the wherewithal and contacts to get the word out to the big publications this time. Since we were pressed for time at ctad we have had over 5 weeks to get our act together. We need to shout it from the rooftops and see the positive press that seems to be reserved only for the likes of the Biogens of the world. We need a full on marketing campaign now. I suspect we won’t get it since we do not have a marketing team in place but over the next few weeks and months we will get exposure. Maybe we get a surprise and they will have something bigger planned ie. partnership or TV ( CNBC, Bloomberg, cnn) exposure in the coming months but really not expected. After all that is what Biogen does. Why not us. It should be us. It should have been us years ago. Let’s hope that Missling has learned from past mistakes and has a better plan this go round. Anyone out there feeling the same way??
News 
Market Data 
Discover 
